Low-dose naltrexone for disease prevention and quality of life
by
Brown N, Panksepp J.
Department of Humanities and Social Sciences,
Embry-Riddle Aeronautical University,
Daytona Beach, FL 32114, United States.
NPHbrown@aol.com
Med Hypotheses. 2009 Mar;72(3):333-7.

ABSTRACT

The use of low-dose naltrexone (LDN) for the treatment and prophylaxis of various bodily disorders is discussed. Accumulating evidence suggests that LDN can promote health supporting immune-modulation which may reduce various oncogenic and inflammatory autoimmune processes. Since LDN can upregulate endogenous opioid activity, it may also have a role in promoting stress resilience, exercise, social bonding, and emotional well-being, as well as amelioration of psychiatric problems such a autism and depression. It is proposed that LDN can be used effectively as a buffer for a large variety of bodily and mental ailments through its ability to beneficially modulate both the immune system and the brain neurochemistries that regulate positive affect.

Pain
'Vivitrex'
Morphine
Tramadol
Naloxone
Nociceptin
Oxycodone
6beta-naltrexol
Naltrexone: suicide risk?
Ultra-low-dose naltrexone
Naltrexone plus buprenorphine
Naltrexone (Trexan) : structure
Naltrexone to treat fibromyalgia
Naltrexone (Trexan) and sexual addicts
Low-dose naltrexone for disease prevention and quality of life (pdf)

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family